Dec 06, 6:05 AM EST
Everything You Need To Know, Right Now.
Stay connected to the biggest stories unfolding in technology.
The IBTech Newsletter keeps you connected to the biggest stories unfolding in technology.
Please enter a valid email
Media & Culture
Astra's Brilinta wins early backing in guidelines
By IBT Staff Reporter on 08/29/10 AT 6:21 PM
AstraZeneca's new blood-thinning drug Brilinta has been given a class 1 recommendation as a treatment option under European medical guidelines, even though it has yet to be approved for sale.
Gene testing war looms for AstraZeneca heart drug
By IBT Staff Reporter on 08/29/10 AT 6:18 PM
Gene testing is shaping up to be a marketing battleground for new blood thinners like AstraZeneca's Brilinta, underscoring the power and limitations of genetics as a tool to predict medical outcomes.
Plavix works in men and women, with differences
By IBT Staff Reporter on 11/10/09 AT 11:14 AM
The popular blood-thinner Plavix prevents heart attacks and strokes in both women and men, but the benefits differ slightly by gender, U.S. researchers said on Monday.
Astra drug beats Plavix without major bleed risk
By IBT Staff Reporter on 08/31/09 AT 9:03 AM
AstraZeneca's new pill Brilinta for preventing heart attacks works better than Plavix, the world's second biggest selling drug, without increasing the amount of life-threatening bleeding, researchers said on Sunday.